# Otago Innovation

> Otago Innovation is a VC fund in Dunedin backing Biotechnology and Veterinary. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dunedin, New Zealand
- Total investments: 2
- Last investment: Jul 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/otago-innovation-ltd/
- Website: https://otagoinnovation.com/

Otago Innovation is a research company that supports researchers from university campuses with opportunities for commercialisation.

## Contacts

5 contacts available for Otago Innovation. Shizune tracks 1 team members at Otago Innovation. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/otago-innovation?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Veterinary | 1 | 50% |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |
| Test and Measurement | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Christensen | CEO | 1 | https://shizune.co/investors/profile/david-christensen-11db |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Amaroq Therapeutics | Amaroq Therapeutics is a biotechnology company that focuses on the development of next-generation cancer therapies. The company's research is centered around long non-coding RNAs, often referred to as the 'dark matter' of the human genome. These molecules, which were only recently discovered, are being explored for their potential incancer treatment. Amaroq Therapeutics is developing novel cancer therapies that specifically target these long non-coding RNAs. The company's work is based on research spun out of the University of Otago in Dunedin, New Zealand. | $9.7M | Seed | Jul 08, 2021 |  |
| InsituGen | InsituGen’s unique cell-free bioassays replicate the natural biological signalling pathways of estrogen and androgen receptors, detecting activity from any known or unknown compound that interferes with steroid hormone receptors. InsituGen’s bioassays and are simple to use, cost-effective, adaptable, fast, sensitive, and accurate. | $2M | Seed | Jul 01, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Booster](https://shizune.co/investors/profile/booster-aa31) — VC Fund, 2 deals together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 1 deal together
- [Cure Kids Ventures](https://shizune.co/investors/profile/cure-kids-ventures) — VC Fund, 1 deal together
- [Enterprise Angels](https://shizune.co/investors/profile/enterprise-angels) — VC Fund, 1 deal together
- [New Zealand Growth Capital Partners](https://shizune.co/investors/profile/new-zealand-growth-capital-partners) — VC Fund, 1 deal together
- [Pacific Channel](https://shizune.co/investors/profile/pacific-channel) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Icehouse Ventures](https://shizune.co/investors/profile/icehouse-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Blackbird Ventures](https://shizune.co/investors/profile/blackbird-ventures-australia) — VC Fund

## Featured in investor lists
- [Life Science VC Funds in Oceania](https://shizune.co/investors/life-science-vc-funds-oceania)

## FAQ

### What does Otago Innovation invest in?

Otago Innovation invests primarily in Biotechnology, Veterinary and Life Science startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Otago Innovation?

Public channels for Otago Innovation include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Otago Innovation?

The team at Otago Innovation includes David Christensen (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co